Comparative pharmacokinetics of coumarin anticoagulants XXI: effect of plasma protein binding on distribution kinetics of warfarin in rats
- PMID: 856978
- DOI: 10.1002/jps.2600660428
Comparative pharmacokinetics of coumarin anticoagulants XXI: effect of plasma protein binding on distribution kinetics of warfarin in rats
Abstract
The purpose of this investigation was to determine the effect of plasma protein binding on the pharmacokinetic parameters for warfarin that are used conventionally to describe its distribution kinetics on the basis of the time course of plasma warfarin concentrations. Following rapid intravenous injection, warfarin concentrations in the plasma of 14 selected adult male rate declined triexponentially, with the terminal exponential phase starting at about 5 hr. The free fraction, f, of warfarin in the serum of individual animals ranged from 0.303 X 10(-2) to 2.89 X 10(-2). The parameters of the equation Ct = Pe-theta + Ae-alphat + Be-betat for plasma concentration Ct at time t were obtained from the experimental data by nonlinear least-squares computer fitting and varied markedly between animals. Strong and highly statistically significant positive correlations with f were obtained for P, B, and beta, but no significant correlation was found for A, theta, and alpha. Rate constants and apparent volumes for a three-compartment open mammillary model with elimination from the central compartment were calculated. No apparent correlation was found between f and the intercompartment distribution rate constants. However, strong positive correlations between f and the elimination rate constant, the volume of the central compartment, and the volume of distribution, V area, were observed. There also was a strong linear correlation between f ant total clearance. Excellent replication of the experimental data was obtained when the experiment were repeated in some animals after 2 weeks. A detailed analysis of practical pharmacokinetic problems associated with and revealed by such repeated experiments is presented.
Similar articles
-
Comparative pharmacokinetics of coumarin anticoagulants XXXI: Effect of plasma protein binding on distribution kinetics of dicumarol in rats.J Pharm Sci. 1977 Dec;66(12):1741-3. doi: 10.1002/jps.2600661222. J Pharm Sci. 1977. PMID: 72819
-
Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.J Pharm Sci. 1975 Oct;64(10):1660-4. doi: 10.1002/jps.2600641015. J Pharm Sci. 1975. PMID: 1195101
-
Comparative pharmacokinetics of coumarin anticoagulants XLIV: Dose-dependent pharmacokinetics of warfarin in rats.J Pharm Sci. 1980 Jan;69(1):9-14. doi: 10.1002/jps.2600690104. J Pharm Sci. 1980. PMID: 7354452
-
Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man.J Pharm Sci. 2003 May;92(5):985-94. doi: 10.1002/jps.10345. J Pharm Sci. 2003. PMID: 12712418
-
Comparative pharmacokinetics of coumarin anticoagulants XXX: Relationship between total clearance and serum protein binding of dicumarol in rats.J Pharm Sci. 1977 Dec;66(12):1739-41. doi: 10.1002/jps.2600661221. J Pharm Sci. 1977. PMID: 72818
Cited by
-
Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat.Eur J Drug Metab Pharmacokinet. 1993 Apr-Jun;18(2):165-71. doi: 10.1007/BF03188792. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8243500
-
Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats.J Pharmacokinet Biopharm. 1988 Feb;16(1):1-12. doi: 10.1007/BF01061859. J Pharmacokinet Biopharm. 1988. PMID: 3373415
-
The effect of hepatic uptake on the disappearance of warfarin from the plasma of rats: a kinetic analysis.J Pharmacokinet Biopharm. 1983 Apr;11(2):127-45. doi: 10.1007/BF01061845. J Pharmacokinet Biopharm. 1983. PMID: 6886970
-
Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patients.Cancer Chemother Pharmacol. 1994;35(2):101-8. doi: 10.1007/BF00686630. Cancer Chemother Pharmacol. 1994. PMID: 7987984 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources